Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.75 RB, SLActive? 14mm, RXD: medical device reports filed with FDA

1,184 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,184
device reports naming the brand
0% of all MAUDE reports · about 158 a year
246
reports, 12 months to August 2026
200 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,184 medical device reports received by FDA name the brand "BLX ?3.75 RB, SLActive? 14mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from January 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

246 reports arrived in the 12 months to August 2026, up 23% from 200 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.7%), loss of osseointegration (11.1%) and difficult to insert (1.6%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01734Sep 2021: 10Oct 2021: 8Nov 2021: 11Dec 2021: 62022Jan 2022: 14Feb 2022: 12Mar 2022: 24Apr 2022: 19May 2022: 21Jun 2022: 13Jul 2022: 17Aug 2022: 21Sep 2022: 11Oct 2022: 19Nov 2022: 3Dec 2022: 102023Jan 2023: 12Feb 2023: 20Mar 2023: 11Apr 2023: 12May 2023: 12Jun 2023: 18Jul 2023: 11Aug 2023: 23Sep 2023: 10Oct 2023: 18Nov 2023: 7Dec 2023: 182024Jan 2024: 9Feb 2024: 17Mar 2024: 16Apr 2024: 22May 2024: 24Jun 2024: 20Jul 2024: 10Aug 2024: 15Sep 2024: 18Oct 2024: 10Nov 2024: 23Dec 2024: 222025Jan 2025: 12Feb 2025: 15Mar 2025: 13Apr 2025: 8May 2025: 0Jun 2025: 34Jul 2025: 20Aug 2025: 25Sep 2025: 17Oct 2025: 18Nov 2025: 21Dec 2025: 202026Jan 2026: 13Feb 2026: 20Mar 2026: 21Apr 2026: 13May 2026: 27Jun 2026: 22Jul 2026: 23Aug 2026: 31

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01032062019: 5920192020: 7720202021: 11320212022: 18420222023: 17220232024: 20620242025: 20320252026: 1702026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,184
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report85.1%1,008
Voluntary report0%0
User facility report0%0
Distributor report14.9%176
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate87373.7%62.8%
Loss of osseointegration13111.1%22.4%
Difficult to insertthe device was hard to insert191.6%0.4%
Fracturea broken bone40.3%1.6%
Difficult to removethe device was hard to remove30.3%0%
Separation failure10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis35329.8%
Painpain, site not specified22519%
Tissue damage968.1%
Hemorrhage/blood loss/bleeding484.1%
Inflammationinflammation484.1%
Swelling/ edema383.2%
Hyperresponsive to stimuli322.7%
Fistula242%
Hypersensitivity/allergic reaction100.8%
Abscessa collection of pus90.8%
Failure of implant80.7%
Swellingswelling40.3%
Inadequate osseointegration30.3%
Numbnessnumbness20.2%
Sinus perforation10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.75 RB, SLActive? 14mm, RXDProduct code DZEAll MAUDE reports
Reports1,1843,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer85.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.75 RB, SLActive? 14mm, RXD reports

How many FDA reports name BLX ?3.75 RB, SLActive? 14mm, RXD?

1,184 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 246 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.7%), loss of osseointegration (11.1%), difficult to insert (1.6%), fracture (0.3%) and difficult to remove (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (85.1%) and distributor reports (14.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.75 RB, SLActive? 14mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.